Gianluca Tornese1, Riccardo Schiaffini2, Enza Mozzillo3, Roberto Franceschi4, Anna Paola Frongia5, Andrea Scaramuzza6. 1. Institute for Maternal and Child Health, IRCCS Burlo Garofolo, 34137 Trieste, Italy. 2. Diabetes Unit, Bambino Gesù Children's Hospital, 00165 Rome, Italy. 3. Regional Center for Pediatric Diabetes, Section of Pediatrics, Department of Translational Medical Science, University of Naples Federico II, 80131 Naples, Italy. 4. Department of Pediatrics, Santa Chiara Hospital Trento, 38122 Trento, Italy. 5. Unit of Pediatric Diabetes, Brotzu Hospital, 09134 Cagliari, Italy. 6. Division of Pediatrics, ASST Cremona, "Ospedale Maggiore di Cremona", Viale Concordia 1, 26100 Cremona, Italy.
Abstract
BACKGROUND: Use of telemedicine for children and adolescents with type 1 diabetes at the beginning of the COVID-19 pandemic was investigated. METHOD: 68 Italian pediatric diabetes centers were invited to complete a survey about telemedicine usage in their pediatric patients, allocated to the no-tech group (multiple daily injections and self-monitoring blood glucose) and the tech group (insulin pump and/or flash- or continuous-glucose monitoring). RESULTS: 60.3% of the centers completed the survey. In both the no-tech and tech groups, the most used ways of communication were generic download portals, instant messaging with personal physicians' mobiles, working emails, and phone calls to physicians' mobiles, with no difference, except for the use of email being higher in the no-tech group (p = 0.03). Seventy-four percent of the centers did not have any systematization and/or reimbursement, with significant differences among regions (p = 0.03). CONCLUSIONS: Almost all Italian pediatric diabetes centers use telemedicine in a semi-volunteering manner, lacking proper codification, reimbursement system, legal traceability, and accreditation system.
BACKGROUND: Use of telemedicine for children and adolescents with type 1 diabetes at the beginning of the COVID-19 pandemic was investigated. METHOD: 68 Italian pediatric diabetes centers were invited to complete a survey about telemedicine usage in their pediatric patients, allocated to the no-tech group (multiple daily injections and self-monitoring blood glucose) and the tech group (insulin pump and/or flash- or continuous-glucose monitoring). RESULTS: 60.3% of the centers completed the survey. In both the no-tech and tech groups, the most used ways of communication were generic download portals, instant messaging with personal physicians' mobiles, working emails, and phone calls to physicians' mobiles, with no difference, except for the use of email being higher in the no-tech group (p = 0.03). Seventy-four percent of the centers did not have any systematization and/or reimbursement, with significant differences among regions (p = 0.03). CONCLUSIONS: Almost all Italian pediatric diabetes centers use telemedicine in a semi-volunteering manner, lacking proper codification, reimbursement system, legal traceability, and accreditation system.
Authors: D Ferorelli; L Nardelli; L Spagnolo; S Corradi; M Silvestre; F Misceo; M Marrone; F Zotti; G Mandarelli; B Solarino; A Dell'Erba Journal: J Prim Care Community Health Date: 2020 Jan-Dec
Authors: Anas Taha; Bara Saad; Bassey Enodien; Marta Bachmann; Daniel M Frey; Stephanie Taha-Mehlitz Journal: Int J Environ Res Public Health Date: 2021-11-15 Impact factor: 3.390
Authors: Marta Bassi; Marina Francesca Strati; Stefano Parodi; Simone Lightwood; Clara Rebora; Francesca Rizza; Giuseppe d'Annunzio; Nicola Minuto; Mohamad Maghnie Journal: Front Public Health Date: 2022-03-22